| Names | |
|---|---|
| Preferred IUPAC name N-(Acetylcarbamoyl)-2-bromo-2-ethylbutanamide | |
| Other names 1-Acetyl-3-(2-bromo-2-ethylbutyryl)urea | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.000.953 |
| EC Number |
|
| KEGG |
|
| MeSH | acecarbromal |
| UNII | |
| |
| |
| Properties | |
| C9H15BrN2O3 | |
| Molar mass | 279.134 g·mol−1 |
| Pharmacology | |
| Oral | |
| Legal status |
|
| Related compounds | |
Related compounds | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Acecarbromal (INN) (brand namesSedamyl,Abasin,Carbased,Paxarel,Sedacetyl, numerous others), also known asacetylcarbromal andacetyladalin, is ahypnotic andsedativedrug of theureide (acylurea) group discovered byBayer in 1917[1] that was formerly marketed in theUnited States andEurope.[2][3] It is also used in combination with extract ofquebracho andvitamin E as a treatment forerectile dysfunction under the brand nameAfrodor in Europe.[4][5][6] Acecarbromal is structurally related to thebarbiturates, which are basically cyclizedureas.[7] Prolonged use is not recommended as it can causebromine poisoning.[7]